These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6613609)
1. Affinity of drugs for cytochrome P-450 determined by inhibition of p-nitrophenetole O-deethylation by rat liver microsomes. Jørgensen L; Johansen T Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):70-7. PubMed ID: 6613609 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a predominantly NADH-dependent O-dealkylating system in rat hepatic microsomes. Kuwahara S; Mannering GJ Biochem Pharmacol; 1985 Dec; 34(24):4215-28. PubMed ID: 3935115 [TBL] [Abstract][Full Text] [Related]
3. Different requirement for cytochrome b5 in NADPH-supported O-deethylation of p-nitrophenetole catalyzed by two types of microsomal cytochrome P-450. Kuwahara S; Omura T Biochem Biophys Res Commun; 1980 Oct; 96(4):1562-8. PubMed ID: 7447942 [No Abstract] [Full Text] [Related]
4. Biotransformation of glyceryl trinitrate by rat aortic cytochrome P450. McDonald BJ; Bennett BM Biochem Pharmacol; 1993 Jan; 45(1):268-70. PubMed ID: 8424819 [TBL] [Abstract][Full Text] [Related]
5. The role of cytochrome P-450 in the synthesis of polar metabolites of aldosterone by microsomes of male rat liver. Latif SA; McDermott MJ; Morris DJ Steroids; 1981 Sep; 38(3):307-19. PubMed ID: 7303036 [TBL] [Abstract][Full Text] [Related]
6. Inhibition by SKF 525-A of 7-ethoxycoumarin O-deethylation in microsomal and the reconstituted monooxygenase systems from PCB-treated rat livers. Kamataki T; Ando M; Ishii K; Kato R Jpn J Pharmacol; 1980 Dec; 30(6):841-51. PubMed ID: 6787292 [TBL] [Abstract][Full Text] [Related]
7. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine. Lakshmi VM; Zenser TV; Davis BB Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548 [TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein. Masubuchi Y; Araki J; Narimatsu S; Suzuki T Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813 [TBL] [Abstract][Full Text] [Related]
9. [Role of cytochrome P-450 in mixed function oxidation and metabolism of anesthetics]. Shigematsu A; Takahashi S; Furukawa T Masui; 1974 Feb; 23(2):89-98. PubMed ID: 4603810 [No Abstract] [Full Text] [Related]
10. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Butler AM; Murray M J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313 [TBL] [Abstract][Full Text] [Related]
11. Dechlorination of halocarbons by microsomes and vesicular reconstituted cytochrome P-450 systems under reductive conditions. Salmon AG; Nash JA; Walklin CM; Freedman RB Br J Ind Med; 1985 May; 42(5):305-11. PubMed ID: 3986141 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction. Kutt H; Verebely K Biochem Pharmacol; 1970 Mar; 19(3):675-86. PubMed ID: 4396252 [No Abstract] [Full Text] [Related]
13. Oxidation of 1,1,1,2-tetrafluoroethane in rat liver microsomes is catalyzed primarily by cytochrome P-450IIE1. Olson MJ; Kim SG; Reidy CA; Johnson JT; Novak RF Drug Metab Dispos; 1991; 19(2):298-303. PubMed ID: 1676626 [TBL] [Abstract][Full Text] [Related]
14. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855 [TBL] [Abstract][Full Text] [Related]
15. Hepatic microsomal oxygenation of aldehydes to carboxylic acids. Watanabe K; Narimatsu S; Yamamoto I; Yoshimura H Biochem Biophys Res Commun; 1990 Feb; 166(3):1308-12. PubMed ID: 2306244 [TBL] [Abstract][Full Text] [Related]
16. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes. Daniels JM; Massey TE Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition of drug metabolic reactions. Gillette J; Sasame H; Stripp B Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379 [No Abstract] [Full Text] [Related]
18. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Reidy GF; Mehta I; Murray M Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of microsomal pathways of oxidation of alcohols and hydroxyl radical scavenging agents with carbon monoxide and cobalt protoporphyrin IX. Krikun G; Cederbaum AI Biochem Pharmacol; 1985 Aug; 34(16):2929-35. PubMed ID: 2992522 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms. Daniel WA; Haduch A; Wójcikowski J Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]